BALAXI PHARMACEUTICALS LIMITED (BALAXI) - Total Liabilities

Latest as of September 2025: Rs844.30 Million INR ≈ $9.13 Million USD

Based on the latest financial reports, BALAXI PHARMACEUTICALS LIMITED (BALAXI) has total liabilities worth Rs844.30 Million INR (≈ $9.13 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BALAXI PHARMACEUTICALS LIMITED cash flow conversion to assess how effectively this company generates cash.

BALAXI PHARMACEUTICALS LIMITED - Total Liabilities Trend (2013–2025)

This chart illustrates how BALAXI PHARMACEUTICALS LIMITED's total liabilities have evolved over time, based on quarterly financial data. Check BALAXI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

BALAXI PHARMACEUTICALS LIMITED Competitors by Total Liabilities

The table below lists competitors of BALAXI PHARMACEUTICALS LIMITED ranked by their total liabilities.

Company	Country	Total Liabilities
N.C. Housing Public Company Limited BK:NCH	Thailand	฿1.83 Billion
Pure Resources Ltd AU:PR1	Australia	AU$284.45K
CLEANTEK Industries Inc V:CTEK	Canada	CA$12.55 Million
Ree Automotive Holding Inc NASDAQ:REE	USA	$53.59 Million
Dgenx Co. Ltd KQ:113810	Korea	₩33.67 Billion
Nature Wood Group Limited American Depositary Shares NASDAQ:NWGL	USA	$13.22 Million
MODERN COMMERCE SA ZY-10 F:8F4	Germany	€22.85 Million
African Media Entertainment JSE:AME	South Africa	ZAC132.29 Million

Liability Composition Analysis (2013–2025)

This chart breaks down BALAXI PHARMACEUTICALS LIMITED's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BALAXI company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BALAXI PHARMACEUTICALS LIMITED's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BALAXI PHARMACEUTICALS LIMITED (2013–2025)

The table below shows the annual total liabilities of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs786.06 Million ≈ $8.50 Million	+37.96%
2024-03-31	Rs569.79 Million ≈ $6.16 Million	+0.33%
2023-03-31	Rs567.89 Million ≈ $6.14 Million	-10.29%
2022-03-31	Rs633.07 Million ≈ $6.85 Million	+82.44%
2021-03-31	Rs347.00 Million ≈ $3.75 Million	+321.88%
2020-03-31	Rs82.25 Million ≈ $889.51K	+217.90%
2019-03-31	Rs25.87 Million ≈ $279.81K	+1859.33%
2018-03-31	Rs1.32 Million ≈ $14.28K	-39.26%
2017-03-31	Rs2.17 Million ≈ $23.51K	+5061.73%
2016-03-31	Rs42.12K ≈ $455.50	-7.73%
2015-03-31	Rs45.65K ≈ $493.67	-98.92%
2014-03-31	Rs4.24 Million ≈ $45.88K	-12.73%
2013-03-31	Rs4.86 Million ≈ $52.57K	--

About BALAXI PHARMACEUTICALS LIMITED

NSE:BALAXI India Biotechnology

Market Cap

$15.90 Million

Rs1.47 Billion INR

Market Cap Rank

#25690 Global

#1432 in India

Share Price

Rs26.63

Change (1 day)

-0.19%

52-Week Range

Rs15.67 - Rs55.98

All Time High

Rs207.74